LC-MS/MS同时测定人血浆及胸水中异烟肼和莫西沙星浓度

雍小兰, 黄娟, 杜晓琳, 刘小娟

中国药学杂志 ›› 2017, Vol. 52 ›› Issue (8) : 661-665.

PDF(1428 KB)
PDF(1428 KB)
中国药学杂志 ›› 2017, Vol. 52 ›› Issue (8) : 661-665. DOI: 10.11669/cpj.2017.08.011
论著

LC-MS/MS同时测定人血浆及胸水中异烟肼和莫西沙星浓度

  • 雍小兰, 黄娟, 杜晓琳, 刘小娟
作者信息 +

Determination of Isoniazid and Moxifloxacin in Human Plasma and Pleural Effusion by LC-MS/MS

  • YONG Xiao-lan, HUANG Juan, DU Xiao-lin, LIU Xiao-juan
Author information +
文章历史 +

摘要

目的 建立高效液相色谱串联质谱(LC-MS/MS)同时测定人血浆及胸水中异烟肼和莫西沙星的浓度。方法 以茶碱为内标,血浆样品及胸水样品经乙腈沉淀蛋白等处理后检测。采用Agilent ZORBAX SB-Aq (4.6 mm×150 mm,5 μm)为分析柱;以乙腈-5 mmol·L-1醋酸铵水溶液(含0.1%甲酸)为流动相,采用电喷雾离子源(ESI),以正离子多反应监测(MRM)方式进行检测,异烟肼m/z 138.1→121.1,莫西沙星m/z 402.1→384.0,茶碱m/z 181.1→124.0。结果 血浆及胸水中内源性物质对测定无干扰,异烟肼和莫西沙星在血浆和胸水的线性范围均为0.1~10 μg·mL-1,日内和日间精密度(RSD)均小于7.56%。结论 本方法特异性强,灵敏度高,测定结果可靠,适用于临床血浆及胸水样品的高通量分析。

Abstract

OBJECTIVE To establish an LC-MS/MS method for the determination of isoniazid and moxifloxacin in human plasma and pleural effusion. METHODS The theophylline was used as internal. The protein of samples were precipitated with acetonitrile. The supernatant was separated on an Agilent ZORBAX SB-Aq (4.6 mm×150 mm, 5 μm). The mobile phase was consisted of acetonitrile and 5 mmol·L-1 ammonium acetate(0.1% formic acid solution). Electrospray ionization (ESI) source was applied and operated in the positive multiple reaction monitoring (MRM) mode. The MS/MS ion transition of m/z was 138.1/121.1 for isoniazid, 402.1→384.0 for moxifloxacin and 181.1/124.0 for theophylline. RESULTS Chromatograms showed no endogenous interfering peaks with blank samples.The calibration curves of isoniazid and moxifloxacin were both linear over the concentration range of 0.1-10 μg·mL-1. Both inter-and intra-day relative standard deviations were less than 7.56%.CONCLUSION The method is specific,sensitive and accurate,and proved to be suitable for the determination of isoniazid and moxifloxacin in human plasma and pleural effusion samples.

关键词

异烟肼 / 莫西沙星 / 高效液相色谱串联质谱 / 血浆 / 胸水

Key words

isoniazid / moxifloxacin / LC-MS/MS / human plasma / pleural effusion

引用本文

导出引用
雍小兰, 黄娟, 杜晓琳, 刘小娟. LC-MS/MS同时测定人血浆及胸水中异烟肼和莫西沙星浓度[J]. 中国药学杂志, 2017, 52(8): 661-665 https://doi.org/10.11669/cpj.2017.08.011
YONG Xiao-lan,HUANG Juan,DU Xiao-lin,LIU Xiao-juan. Determination of Isoniazid and Moxifloxacin in Human Plasma and Pleural Effusion by LC-MS/MS[J]. Chinese Pharmaceutical Journal, 2017, 52(8): 661-665 https://doi.org/10.11669/cpj.2017.08.011
中图分类号: R969.1   

参考文献

[1] CHEN Z, LIANG J Q, WANG J H, et al. Moxifloxacin plus standard First-line therapy in the treatment of pulmonary tuberculosis: ameta-analysis[J]. Tuberculosis (Edinb), 2015, 95(4): 490-496.
[2] ZHU H, LI P, LU Y. LC-MS/MS Determination of isoniazid,ethambutol and pyrazinamide in human plasma [J]. Chin J Pharm Anal(药物分析杂志), 2012, 32 (6):945-949.
[3] ZHAO G R, PENG M L, SHEN J, et al. LC-MS/MS Determination of isoniazid,ethambutol and pyrazinamide in human plasma[J]. Chin J Drug Appl Monit(中国药物应用与监测),2015,12(1):16-19.
[4] JIANG J,JIAO H S, ZHANG H Y, et al. Preparation of isoniazid delayed release implant and the release behavior in rabbits[J]. Chin Pharm J(中国药学杂志), 2014, 49 (17):1535-1539.
[5] ZHANG Y X, ZHANG B, FU Q. Determination of moxifloxacin in human serum and cerebrospinal fluid by HPLC [J]. Chin Pharm J(中国药学杂志), 2011, 46 (22):1746-1748.
[6] MEI H K, WANG R, BAI N, et al. Determination of moxifloxacin in human plasma by HPLC-MS/MS [J]. Chin J Drug Appl Monit(中国药物应用与监测), 2013, 10 (2):83-86.
[7] WANG S M, ZHOU H, GUO S J, et al. Bioequivalence and safety evaluation of moxifloxacin hydrochloride tablets in healthy volunteers [J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2015, 31 (24):2414-2416.
[8] CHEN Y. Effects of moxifloxacin combined with regimen in the treatment of patients with drug-resistant pulmonary tuberculosis [J]. J Clin Pulm Med(临床肺科杂志), 2013, 18 (2):309-311.
[9] SHI M S, WENG C X, XIANG H, et al. Clinical observation of moxifloxacin combined with Jiehe Pill in the treatment of multidrug-resistant tuberculosis [J]. J China Pharm(中国药房), 2015, 26 (36):5092-5094.

基金

四川省科技计划项目(2014JY0149)
PDF(1428 KB)

Accesses

Citation

Detail

段落导航
相关文章

/